| # | Drug | Count |
|---|---|---|
| 0 | FLUDARABINE PHOSPHATE | 584 |
| 1 | MYCOPHENOLATE MOFETIL | 551 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 551 |
| 3 | CYCLOSPORINE | 526 |
| 4 | TACROLIMUS | 459 |
| 5 | METHOTREXATE SODIUM | 430 |
| 6 | METHOTREXATE | 408 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 386 |
| 8 | TACROLIMUS OINTMENT 0.1% | 386 |
| 9 | CYCLOPHOSPHAMIDE | 357 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRINCIDOFOVIR | 7 | 0.0504 |
| 1 | ANTIFUNGAL LIQUID SPRAY | 7 | 0.0372 |
| 2 | TREOSULFAN | 101 | 0.0366 |
| 3 | THIOTEPA | 278 | 0.0285 |
| 4 | TOLNAFTATE 1% | 7 | 0.0241 |
| 5 | CIDOFOVIR ANHYDROUS | 24 | 0.0166 |
| 6 | BUSULFAN | 264 | 0.0166 |
| 7 | FLUDARABINE PHOSPHATE | 584 | 0.0147 |
| 8 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 112 | 0.0138 |
| 9 | IBRITUMOMAB TIUXETAN | 18 | 0.0118 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 659 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 526 |
| 2 | Corticosteroid [EPC] | 510 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 408 |
| 4 | Azole Antifungal [EPC] | 183 |
| 5 | Kinase Inhibitor [EPC] | 168 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 147 |
| 7 | Janus Kinase Inhibitor [EPC] | 124 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 121 |
| 9 | Immunoglobulin G [EPC] | 119 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 24 | 0.0074 |
| 1 | Echinocandin Antifungal [EPC] | 56 | 0.0068 |
| 2 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 13 | 0.0053 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 98 | 0.0051 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 526 | 0.0040 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 86 | 0.0039 |
| 6 | Chemokine Receptor Type 4 Interaction [EPC] | 4 | 0.0029 |
| 7 | Alkylating Drug [EPC] | 659 | 0.0027 |
| 8 | CD22-directed Immunoconjugate [EPC] | 8 | 0.0027 |
| 9 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |